Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Danielle Rebibo is active.

Publication


Featured researches published by Danielle Rebibo.


Transfusion | 2002

Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998

Georges Andreu; P. Morel; Francois Forestier; Joëlle Debeir; Danielle Rebibo; Gérard Janvier; Patrick Herve

BACKGROUND : Hemovigilance networks have been introduced in several countries to improve knowledge of blood transfusion‐related morbidity and mortality. The general organization of the French network and its results from 1994 through March 1999 are presented here.


Transfusion | 2011

Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.

Yves Ozier; Jean-Yves Muller; Paul-Michel Mertes; Philippe Renaudier; Philippe Aguilon; N. Canivet; P. Fabrigli; Danielle Rebibo; Mahdi Tazerout; Catherine Trophilme; Béatrice Willaert; Cyril Caldani

BACKGROUND: Transfusion‐related acute lung injury (TRALI) is a major cause of transfusion‐related mortality and morbidity. Epidemiologic studies using data from national transfusion schemes can help achieve a better understanding of TRALI incidence.


Transfusion | 2015

Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008.

Bruno Lafeuillade; François Eb; Nadra Ounnoughene; Rachel Petermann; Gérald Daurat; Gérard Huyghe; Mai-Phuong Vo Mai; Cyril Caldani; Danielle Rebibo; Pierre Weinbreck

Regarding blood safety, transfusion‐transmitted bacterial infection (TTBI) remains the most frequent infectious risk. The incidence of these episodes needs to be assessed and updated frequently to accurately manage this risk.


Revista Brasileira De Hematologia E Hemoterapia | 2000

Hemovigilance in France

Patrick Hervé; Marie-Françoise Leconte des Floris; Danielle Rebibo; Pascal Morei; Georges Andreu

No relato sao apresentados aspectos da organizacao da hemovigilância na Franca, o sistema de alerta relacionado com reacoes transfusionais indesejaveis e a busca de receptores sorologicamente positivos.


Transfusion Clinique Et Biologique | 2010

Œdèmes pulmonaires transfusionnels : classification des cas notifiés en hémovigilance

Yves Ozier; Philippe Renaudier; Cyril Caldani; P. Aguilon; N. Canivet; P. Fabrigli; Paul-Michel Mertes; Jean-Yves Muller; Danielle Rebibo; M. Tazerout; C. Trophilme; Béatrice Willaert; M. Carlier

Pulmonary oedema after transfusion of blood products may be hydrostatic (transfusion-associated circulatory overload [taco]) or exsudative (transfusion-related acute lung injury [trali]). Both conditions have been recognized as major hazards to transfusion recipients. Risk characterization is necessary to improve safety and to monitor trends in the national blood transfusion system. A collaborative multidisciplinary working group of the French National Hemovigilance Committee has proposed an analysis framework for case definitions and classification. The method relies on internationally used definitions and is adapted to the codification procedures used in the french transfusion incident reports electronic data management.


Transfusion Medicine and Hemotherapy | 2008

Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results.

Philippe Renaudier; Syvie Schlanger; Mai-Phuong Vo Mai; Nadra Ounnoughene; Pascal Breton; Stéphane Cheze; Albane Girard; Lisette Hauser; Jean François Legras; Hélène Odent-Malaure; Danielle Rebibo; Chantal Waller; Béatrice Willaert; Cyril Caldani

The French Hemovigilance Network has been established in 1994 and records all adverse events associated with the transfusion of a labile blood products (LBP) regardless of their severity. From 1994 to 2006 35,423,172 LBP were issued, 85,812 adverse transfusion reactions notified, and 139 cases of transfusion related acute lung injury (TRALI) observed. The LBP most at risk is fresh frozen plasma (FFP), followed by platelets concentrates (PC) and packed red cells (PRC). However, because the use of FFP is not frequent in France, it only accounts for about 10% of TRALI, whereas PRC and PC are involved in the remaining cases. In no case, pooled FFP treated with solvent-detergent were involved. Patients’ profiles are peculiar with a high disease burden. Therefore, targeting a prevention policy only on FFP would result in a marginal reduction of TRALI in France.


Transfusion Clinique Et Biologique | 2010

La gestion des informations post-don: un élément fondamental de la sécurité transfusionnelle

I. Hervé; M. Simonet; Danielle Rebibo; M.-F. Leconte des Floris; M. Taouqi-Le Cann; S. Jbilou; A. Brunet

Post donation information management is a fundamental axis of haemovigilance in terms of blood safety. It requires an organization ensuring a permanent reactivity, a good sensitization of French National Blood Service professionals and needs also a strong awareness of blood donors. Previous identification of stakeholders to warn during these kinds of alerts is essential to avoid the use of any blood product presenting a potential risk. The recent implementation of a consensual internal document aims to target the reinforcement of a homogeneous decision-making process, combining blood product self-sufficiency and above all recipient safety.


Transfusion Medicine and Hemotherapy | 2008

Latest Publications in Cytometry Part A You Should Not Miss

Hans-Gert Heuft; Wolfgang Mende; Rainer Blasczyk; Franz Weinauer; Béatrice Willaert; Mai-Phuong Vo Mai; Cyril Caldani; Philippe Renaudier; Syvie Schlanger; Nadra Ounnoughene; Pascal Breton; Stéphane Cheze; Albane Girard; Lisette Hauser; Jean François Legras; Hélène Odent-Malaure; Danielle Rebibo; Chantal Waller; Catherine E. Chapman; Lorna M. Williamson; Markus Jutzi; Guy Levy; Behrouz Mansouri Taleghani; Peter Hellstern; Walter E. Hitzler; Britta Engelhardt; Mark A. Popovsky; Matthias Hecker; Hans-Dieter Walmrath; Werner Seeger

Service


Transfusion and Apheresis Science | 2004

The French Haemovigilance System : organization and results for 2003

Danielle Rebibo; Lisette Hauser; Ahmed Slimani; Patrick Herve; Georges Andreu


The Journal of Allergy and Clinical Immunology | 2012

Methylene blue–treated plasma: An increased allergy risk?

Paul-Michel Mertes; P. Demoly; Annick Alpérovitch; A. Bazin; Jacques Bienvenu; Cyril Caldani; Bernard Lamy; Dominique Laroche; Marie-Françoise Leconte des Floris; Jean-Yves Py; Danielle Rebibo; Béatrice Willaert; Christian Drouet; M. Carlier; André Lienhart

Collaboration


Dive into the Danielle Rebibo's collaboration.

Top Co-Authors

Avatar

Cyril Caldani

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Béatrice Willaert

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Philippe Renaudier

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Nadra Ounnoughene

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Jean François Legras

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Mai-Phuong Vo Mai

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Yves Ozier

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Patrick Herve

University of Franche-Comté

View shared research outputs
Top Co-Authors

Avatar

M. Carlier

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge